Author: Eric Jones

Expansion exemplifies the company’s commitment to meet the highest security and compliance standards

TORONTO – October 12, 2022 – (Newswire.com)

Smile CDR Inc. (doing business as Smile Digital Health), a leading health data and integration company, today announced it has passed an Amazon Web Services (AWS) Foundational Technical Review (FTR) and has achieved Amazon HealthLake (AHL) Connector partner status in the AWS Partner Network (APN). Healthcare organizations can expect Smile Digital Health running on AWS to provide a best-in-class data fabric platform along with the confidence that it is meeting various regulatory and compliance requirements in the U.S. and the EU when storing and sharing their sensitive health data via the platform. Smile Digital Health first announced its work with AWS in March, and this expansion represents the continual growth of that relationship.

“Our ongoing work with AWS demonstrates the deep collaboration between our companies, delivering the many benefits of the Smile Digital Health data fabric platform running in a world-class hyperscale environment. Having partner status provides our customers with substantial benefits including additional security, dependability and operational excellence,” said Duncan Weatherston, Chief Executive Officer, Smile Digital Health. “Healthcare organizations — and in turn their patients — are well served by access to our scalable, high-performing, resilient and efficient data fabric platform on the leading cloud infrastructure.”

The expansion and scope of work includes two key elements:

• Becoming an Amazon HealthLake (AHL) Connector Partner, demonstrating the company’s ability to help transform existing healthcare data in real time into the required format, including standard Fast Healthcare Interoperability Resources (FHIR^®) format, so the data can be used across AHL applications and services.
   
• Passing the AWS Foundational Technical Review (FTR), which helps identify and mitigate technical risks in solutions built by independent software vendors (ISVs). Smile Digital Health’s solutions were evaluated by a subset of AWS Well-Architected best practices. As part of the review, Smile Digital Health’s reference architecture was approved to be deployed on Amazon Elastic Kubernetes Services (Amazon EKS), a managed container service to run and scale Kubernetes applications in the cloud or on-premises, and Amazon Aurora and Amazon Relational Database Service (Amazon RDS) for PostgreSQL to ensure a performant, cost-effective, secure and scalable solution.

“Our customers can expect Smile Digital Health to continuously meet and often exceed regulatory and compliance requirements when storing and sharing their sensitive health data via our data fabric platform. In that sense, we continue to guarantee the highest security and compliance standards,” said James Agnew, Chief Technology Officer, Smile Digital Health.

Smile Digital Health’s work on AWS continues to simplify the interoperability process between various data platforms, allowing for better health journey outcomes between patients, providers and health systems, and reducing information technology barriers.

About Smile Digital Health

Smile Digital Health is a health information technology company focused on delivering better global health through open standards. Our enterprise-grade, health data fabric and exchange platform fuels healthcare’s digital transformation and accelerates value creation across all patient journeys at scale. | Part of VUGA Media Group | Fair Use | Terms of Use | Get Published our HL7® FHIR® standard-based clinical data repository (#SmileInside), our platform enables collaboration and allows organizations to ingest, transform, store, enrich, analyze, aggregate, and meaningfully share health information to power digital transformation. We prepare healthcare providers, payers, researchers, and life sciences organizations for a connected future beyond legacy systems, adding new value through intelligent use of information and ultimately delivering better patient outcomes. We help healthcare organizations confidently #ChooseOpenStandards with the goal of #BetterGlobalHealth. For more information, visit SmileDigitalHealth.com.

Contact Information:

Lucy Railton

Director of Marketing
[email protected]

(800) 683-1318

Press Release Service
by
Newswire.com

Original Source:

Smile Digital Health Expands Work on AWS

Continue Reading

Signs New Distribution Partners in Three Countries

LAWRENCEVILLE, Ga. – October 12, 2022 …

Continue Reading

Designee builds on commitment to furthering excellence in the healthcare sector’s information security and privacy programs

PORTLAND, Ore. – October 12, 2022 – (Newswire.com)

Apgar & Associates, LLC today announced that it is designated as a HITRUST Readiness Licensee. With this achievement, Apgar & Associates is approved by HITRUST to perform consulting and readiness work for organizations looking to adopt the HITRUST CSF or prepare for their first assessment. For over a decade, the consultancy has provided information security and privacy services that encompass strategic planning for risk management and compliance programs, as well as consulting on security incidence response, risk analysis, and policy and procedures. 

HITRUST Readiness Licensees help uphold information security and privacy standards for various industries of varying size and complexity by assisting clients with the adoption of the HITRUST CSF framework, implementation, and remediation efforts following adoption, and facilitated self-assessments.

“We’re very pleased to receive the HITRUST Readiness designation. It feels like a natural progression in our firm’s commitment to furthering excellence in the healthcare sector’s information security and privacy programs,” stated Julia Huddleston, CIPP/US, CIPM, CCSFP, and Principal Consultant at Apgar & Associates, LLC. “We look forward to helping guide healthcare providers and their business associates through the what and how of readying for the HITRUST assessment.”

“Readiness Licensees meet the criteria to become trusted and independent resources for clients needing to improve their security posture,” said Matthew Datel, Director, Education & Strategic Initiatives at HITRUST. “Readiness Licensees are helpful in providing qualified third-party reviews for clients preparing for or seeking HITRUST CSF Certification.”

About Apgar & Associates

The consultancy’s information security and privacy services encompass strategic planning for risk management and compliance programs, as well as consulting on security incidence response, risk analysis, and policy and procedures.

The team also helps organizations decide which of the various industry certifications aligns best with the business’ privacy and information security strategy. For more information about Apgar & Associates’ consulting services, such as HITRUST Readiness, please contact the company at 503-384-2538 or visit its website at https://apgarandassoc.com/.

Contact Information:

Nora Haile

Marketing Consultant
[email protected]

520-425-6498

Press Release Service
by
Newswire.com

Original Source:

Apgar & Associates Achieves HITRUST® Readiness Licensee Designation

Continue Reading

The agreement brings together two industry leaders, leveraging complementary strengths to enhance support of doctors in building successful dental practices. This new education platform is called Group Dentistry Instit…

Continue Reading

Torrential rain sparked flash floods across northern Georgia, with more than 12 inches of rain falling in areas in a matter of hours.

Continue Reading

Dr. Korb Dr. Korb with her dogs, Charlie and Tucker
CHARLESTON, S.C. – October 11, 2022 – (Newswire.com)
…

Continue Reading

Ambit to showcase its prevalence projection approach, co-developed with Praxis, for rare developmental and epileptic encephalopathies (DEEs) as a Platform Presentation at this year’s annual Child Neurology Society meeting

CINCINNATI – October 11, 2022 – (Newswire.com)

Ambit^®, a data and technology-enabled biopharma services company, today announced that leadership will debut Ambit’s data-driven methodology for projecting prevalence and diagnosis rates for difficult-to-quantify DEEs at the 51^st Annual Child Neurology Society Meeting on Oct. 13, 2022. Ambit’s analytics team has developed this methodology in collaboration with Praxis Precision Medicines, Inc. (NASDAQ: PRAX) and the UCSF Weill Institute for Neurosciences and Benioff Children’s Hospitals.

For many rare DEEs, reliable prevalence estimates are not available. With a robust and growing pipeline of precision medicine therapies in rare epilepsy and neurodevelopmental disorders, estimating the prevalence of these conditions with a data-driven methodology can be highly valuable to drug developers, medical device companies and other healthcare decision-makers.

“Ambit’s expertise in a data-driven approach to prevalence projections for rare neurological conditions has allowed Praxis to characterize DEE populations with a high degree of confidence,” said Marcio Souza, president and chief executive officer of Praxis. “As we seek to bring first-in-class, potentially disease-modifying therapies to DEE patients in need, our collaboration with Ambit has been invaluable in increasing our understanding of these patient groups.”

Despite the availability of sponsored genetic testing and increased awareness of the benefit of genetic testing, over 50% of patients with rare DEEs remain undiagnosed. Sizing these patient populations and diagnosis rates underscores the importance of earlier genetic testing for unexplained seizure disorders and rare DEEs. “Even today, the path to accurate diagnosis and appropriate care for rare genetic epilepsies can be long and full of challenges,” said Adam Numis, M.D., of the UCSF Benioff Children’s Hospital. “Ambit’s methodology underscores the need for more treatment options to improve outcomes and quality of life for the rare DEE population.”

Ambit chief executive officer, Robert Sederman, will present this methodology on Oct. 13 as part of the Platform II Presentation Session (PL2-1) at the 2022 Annual Child Neurology Society Meeting. Presentations will run from 7-9 a.m. ET in the Junior Ballroom CD at the Duke Energy Center. Ambit will be presenting from 7-7:15 a.m. The associated abstract will be published in a supplement to the October issue of Annals of Neurology.

“We are excited to partner with Praxis and UCSF to showcase Ambit’s DEE projection methodology at this year’s meeting and, ultimately, see the impact of this collaboration on greater access to accurate diagnosis and treatment for patients with rare DEEs in the future,” said Sederman.
 

About Ambit Inc.

Ambit Inc.^® is a data and technology-enabled biopharma and healthcare services company with a focus on rare and specialty disease. Ambit’s patient identification services drive patient activation and earlier diagnosis for patients that may be suffering from rare diseases. Ambit’s analytics and professional services support rare and specialty biopharma across the clinical development and commercialization of potentially life-changing therapies. To learn more about Ambit’s DEE Projection approach and other capabilities, please reach out to [email protected].

About Praxis

Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying insights from genetic epilepsies to both rare and more prevalent neurological disorders, using our understanding of shared biological targets and circuits in the brain. Praxis has established a broad portfolio with multiple programs, including product candidates across movement disorders, epilepsy and psychiatric disorders, with four clinical-stage product candidates. For more information, please visit www.praxismedicines.com and follow us on LinkedIn and Twitter.  

Contact Information:

Alexis Burbank

Marketing, Ambit Inc.
[email protected]

Press Release Service
by
Newswire.com

Original Source:

Ambit Inc. to Present Novel Projection Methodology for Rare Developmental and Epileptic Encephalopathies (DEEs) at the 2022 Child Neurology Society Annual Meeting

Continue Reading

The American Academy of Stem Cell Physicians will be hosting its fall Scientific Congress in Chicago, IL, on Oct. 28, 2022.

AASCP Chicago lecture …

Continue Reading

ALBANY, N.Y. – October 11, 2022 – (Newswire.com)

In celebration of Cybersecurity Awareness Month, Cybersecurity pioneer, Cytex, Inc. and Mohawk Insurance announce their partnership to empower clients to protect their data assets from malicious cyberattacks and prevent data breaches with state-of-the-art DNS firewall security and Phishing Simulation.

Tom O’Connor, Mohawk Insurance Services Managing Partner, commented, “Mohawk Insurance is always looking for ways to make our clients more successful by providing added value services that protect their physical and digital assets.  We chose Cytex as a partner because they’ve pioneered a comprehensive platform solution for cybersecurity that provides a high level of security, visibility, and actionable data to make our clients safer in today’s connected business environment.” 

Cytex, Inc. CEO Andrew Surwilo remarked, “Remote work environments, the proliferation of connected devices, and cloud apps have created new cyber risks that can’t be defended with traditional firewalls. We are thrilled to partner with Mohawk Insurance to protect Mohawk’s clients against emerging cyber threats and data breaches.”

As small to midsize businesses continue to be the target of email phishing campaigns, Mohawk is bringing its clients a solution that increases employee cyber-threat awareness in a meaningful way. “We know that phishing campaigns targeting employee emails are one of the top ways businesses are compromised, and we recognize that the most effective way to combat this threat is to create a culture of cybersecurity awareness at the employee level through education. The Cytex Platform seamlessly combines protection, awareness, and education in an easy to implement and use dashboard,” O’Connor said. 

Under the Cytex -Mohawk Insurance program, clients receive free implementation of both the DNS firewall security defense and Phishing Simulation modules within the Cytex Unified Platform for $75 per month. Mohawk is proud to offer these services and is committed to being a proactive partner in safeguarding the value its clients continue to create. To take advantage of this program, businesses can sign up at: https://cytex.io/cytex_mohawk.html

About Cytex, Inc. Cytex is a first-of-its-kind, SaaS-based platform solution that combines cybersecurity, network operations, data supply chain monitoring, and compliance automation. Cytex patent-pending technology eliminates application sprawl by combining functionality across cybersecurity and compliance domains. https://cytex.i

About Mohawk Insurance Services

Founded in 2022, Mohawk Insurance Services brings more than 100 years of combined insurance experience to service businesses, organizations, and individuals throughout New York and across the nation. We represent the leading regional and national insurance companies, providing our clients with the most comprehensive coverage, price, and service options available in the marketplace. With experienced team members in global partnerships and complex policies, we’re determined to find the best solutions for businesses big and small. https://www.mohawkinsurance.com

Contact Information:

Andrew Surwilo

CEO
[email protected]

703-932-8178

Tom O’Connor

Managing Partner
[email protected]

518-360-0030 ext. 103

Press Release Service
by
Newswire.com

Original Source:

Cytex, Inc and Mohawk Insurance Services Announce Strategic Partnership to Bring Active Cybersecurity Protection and Education to Its Clients

Continue Reading

The biggest maternity show of 2022 is Saturday, Oct. 22. The expo is online and free. Get tickets today. More info at happymama.global.

Happy Mama …

Continue Reading